- Fund Type: SICAV
- Objective: Region Fund-European
- Asset Class: Equity
- Geographic Focus: European Region
Snapshot for Amonis - Equity Europe (AMESMCI)
| Year To Date: | +11.54% | 3-Month: | +8.53% | 3-Year: | +8.58% | 52-Week Range: | 4,300.39 - 5,762.58 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +7.69% | 1-Year: | +29.31% | 5-Year: | +2.56% | Beta vs MXEUSC: | 0.78 |
Fund Profile & Information for AMESMCI
Amonis - Equity Europe is an open-end fund registered in Belgium. The goal is to achieve capitalexpansion through stockrate increases and dividends. The Fund invests mainly in listed European companies.
| Inception Date: | 12-28-2007 | Telephone: | 32-02-774-4440 |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | www.amonis.be | ||
Fundamentals for AMESMCI
| NAV | (on 2013-05-16) 5,762.58 |
|---|---|
| Assets (M) | (on 2013-05-16) 37.67 |
| Fund Leveraged | N |
| Minimum Investment | 50,000.00 |
| Minimum Subsequent Investment | - |
Dividends for AMESMCI
No dividends reported
Fees & Expenses for AMESMCI
| Front Load | - |
|---|---|
| Back Load | - |
| Current Mgmt Fee | 0.30 |
| Redemption Fee | - |
| 12b1 Fee | - |
| Expense Ratio | 1.22 |
Top Fund Holdings for AMESMCI
Filing Date: 12/31/2012| Name | Position | Value | % of Total |
|---|---|---|---|
| Nestle SA | 18,514 | 914,347 | 3.044% |
| HSBC Holdings PLC | 103,601 | 826,279 | 2.751% |
| Novartis AG | 13,175 | 627,199 | 2.088% |
| Roche Holding AG | 4,041 | 616,129 | 2.051% |
| BP PLC | 107,101 | 560,924 | 1.868% |
| Royal Dutch Shell PLC | 21,347 | 558,480 | 1.859% |
| Vodafone Group PLC | 279,779 | 532,756 | 1.774% |
| Sanofi | 6,844 | 488,593 | 1.627% |
| Total SA | 12,196 | 475,766 | 1.584% |
| GlaxoSmithKline PLC | 28,316 | 466,057 | 1.552% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page